One of the most common birth defects in the world is hearing loss. Every 1,000 babies are born with permanent hearing loss in one or both ears. Hearing loss can have a significant impact on a baby's development.
CapitalBio created Hereditary #Deafness Gene Detection Item using semiconductor sequencing technology. It can identify #100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection is more than 99.9 percent accurate.
The Bioelectron gene sequencer 4000 platform was created in collaboration with Thermo Fisher. It can detect 384 samples at the same time.
Diagnosis of Colorectal Cancer from Three AspectsApril 4, 2023Coloretal cancer is a common digestive tract tumor with high malignancy. If it is not detected timely, the patient's condition is usually already in the middle or late stages. There are three main...view
Working Principle of Deep Resolution DNA Microarray ScannerApril 10, 2024As an important tool in modern biotechnology, DNA microarray scanners play a vital role in genomics, disease diagnosis, drug research and development, and other fields. They can achieve rapid and accu...view
The Development History of Genetic Sequencer InstrumentApril 4, 2023The first generation of DNA genetic sequencer technologyIn 1977, Sanger proposed the classic dideoxy nucleotide termination sequencing method. Subsequently, based on the Sanger method, in the mid-1980...view
The Role of Microfluidic Platforms in Drug Development and TestingJuly 18, 2024In the dynamic landscape of drug development and testing, the advent of microfluidic technology stands as a revolutionary advancement. Among the frontrunners in this innovation is CapitalBio, a brand ...view
The Benefits of Preimplantation TestingApril 16, 2025What Is Preimplantation Testing?Preimplantation testing refers to the chromosomal or specific gene testing of embryos before implantation. This is done to select embryos that do not carry genetic defe...view